Prevalence of oral glucocorticoid usage in the United States: A general population perspective

2012402 citationsJournal Article

Authors

Abstract

Based on NHANES data from 1999-2008, it is estimated that the prevalence of glucocorticoid use in the US is 1.2%, with a long duration of use and infrequent use of antiosteoporotic medications compared to other estimates.

Topics & Keywords

Bone health and treatments Thyroid Disorders and Treatments Adrenal Hormones and Disorders

UN Sustainable Development Goals

Zero hunger

Publication Details

Published in: Arthritis Care & Research

Volume 65, Issue 2, pp. 294-298

DOI: 10.1002/acr.21796

Field-Weighted Citation Impact: 4.84